The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – February 2025 appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 6 January 2025) has been published and includes articles on: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation Letters and medicine recalls sent to healthcare professionals in December 2024 To see the latest [...]
The post MHRA Drug Safety Update: January 2025 appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Memantine (Valios®) 5mg orodispersible tablets sugar free MSN/2025/005 Tier 2 – medium impact Date of issue: 28th January 2025 Memantine (Valios®) 5mg orodispersible tablets sugar free are out of stock until late April 2025. Memantine (Valios®) 5 mg/10 mg/15 mg/20 mg [...]
The post Medicine Supply Notification: Memantine (Valios® ) 5mg orodispersible tablets sugar free appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has entered into consultation with Community Pharmacy England (CPE) regarding the 2024/25 and 2025/26 funding contractual framework. The discussions will set the future direction for community pharmacy as it plays a vital role in supporting delivery of the reforms set out in the government’s Plan for Change. [...]
The post Government opens discussions with Community Pharmacy England over 25/26 funding contract appeared first on Community Pharmacy England.
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has agreed to retrospectively adjust the reimbursement price of Gaviscon Infant oral powder 15 dual dose sachets for EPS prescriptions dispensed between May 2023 to November 2024. The term ‘dual dose sachets’ was updated to [...]
The post Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets appeared first on Community Pharmacy England.
Recent Comments